ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LRMR Larimar Therapeutics Inc

6.89
0.28 (4.24%)
After Hours
Last Updated: 17:47:08
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -9.09M-8.89M-8.69M-8.51M-10.44M-7.64M-9.62M-10.34M
Pre Tax Income -9.13M-8.94M-8.67M-8.32M-9.43M-6.53M-8.37M-9.06M
Net Income -9.13M-8.94M-8.67M-8.32M-9.43M-6.53M-8.37M-9.06M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -9.13M-8.94M-8.67M-8.36M-9.43M-6.53M-8.37M-9.06M
EBITDA -9.12M-8.81M-8.61M-8.44M-10.48M-7.56M-9.54M-10.26M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -58.23M-53M-61.12M-45.65M-42.8M-50.47M-36.53M-41.76M
Pre Tax Income -57.88M-52.03M-61.37M-45.41M-42.48M-50.64M-35.36M-36.95M
Net Income -57.88M-52.03M-61.37M-45.41M-42.48M-50.64M-35.36M-36.95M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.118-1.893-1.646-1.213-2.764-2.859-0.817-0.842
EBIT -58.23M-53M-61.12M-45.65M-42.48M-50.64M-35.36M-36.95M
EBITDA -58.01M-52.81M-60.86M-45.39M-42.65M-50.27M-36.33M-41.45M

Your Recent History

Delayed Upgrade Clock